US-USA-TRUMP-MUSK-REGULATORS:Explainer-Does escalating spat with Trump pose regulatory threat for Musk businesses?

Elon Musk’s decision to go all-in on Donald Trump never made much sense. His scorched-earth approach to breaking up with Trump is even harder to square.

Donald Trump and Elon Musk are in a public fight. It started over tax policy. Trump says he cut Musk out of EV decisions.

In September, the FAA proposed a $633,000 fine against SpaceX for failing to follow license requirements in 2023 before two ...

The risk U.S. transportation, environmental, communications and other regulators will take aim at Elon Musk's many businesses ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

It was 2006 when Dr. Daniel Gibbs first noticed he was losing his sense of smell. But it wasn't what he didn't smell that ...

Pomerantz LLP is investigating claims on behalf of investors of  Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") . Such investors are advised to contact Danielle Peyton at ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety ...